Pathologic response and survival after cisplatin, pemetrexed, and bevacizumab followed by surgery for clinical stage II/IIIA non-squamous non-small cell lung cancer

被引：0
|
作者：
Tsutani, Y. [1 ]
Miyata, Y. [1 ]
Suzuki, K. [2 ]
Takamochi, K. [2 ]
Tanaka, F. [3 ]
Nakayama, H. [4 ]
Yamashita, Y. [5 ]
Oda, M. [6 ]
Tsuboi, M. [7 ]
Okada, M. [1 ]
机构：
[1] Hiroshima Univ, Surg Oncol, Hiroshima, Japan
[2] Juntendo Univ, Gen Thorac Surg, Sch Med, Tokyo, Japan
[3] Univ Occupat & Environm Hlth, Thorac Surg, Kitakyushu, Fukuoka, Japan
[4] Kanagawa Canc Ctr, Thorac Surg, Yokohama, Kanagawa, Japan
[5] Chugoku Canc Ctr, Kure Med Ctr, Thorac Surg, Kure, Japan
[6] Kanazawa Univ, Thorac Surg, Kanazawa, Ishikawa, Japan
[7] Natl Canc Ctr Hosp East, Thorac Surg & Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw382.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1197P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy in non-squamous non-small-cell lung cancer.
    Karayama, Masato
    Inui, Naoki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Yokomura, Koshi
    Koshimizu, Naoki
    Sato, Masaki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Imokawa, Shiro
    Suda, Takafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer
    Karayama, Masato
    Inui, Naoki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Kuroishi, Shigeki
    Yokomura, Koshi
    Koshimizu, Naoki
    Sato, Masaki
    Toyoshima, Mikio
    Shirai, Toshihiro
    Masuda, Masafumi
    Yamada, Takashi
    Imokawa, Shiro
    Suda, Takafumi
    EUROPEAN JOURNAL OF CANCER, 2016, 58 : 30 - 37
  • [43] Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
    Belani, Chandra P.
    Yamamoto, Nobuyuki
    Bondarenko, Igor M.
    Poltoratskiy, Artem
    Novello, Silvia
    Tang, Jie
    Bycott, Paul
    Niethammer, Andreas G.
    Ingrosso, Antonella
    Kim, Sinil
    Scagliotti, Giorgio V.
    BMC CANCER, 2014, 14
  • [44] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [45] Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer
    Chandra P Belani
    Nobuyuki Yamamoto
    Igor M Bondarenko
    Artem Poltoratskiy
    Silvia Novello
    Jie Tang
    Paul Bycott
    Andreas G Niethammer
    Antonella Ingrosso
    Sinil Kim
    Giorgio V Scagliotti
    BMC Cancer, 14
  • [46] A phase II first line study of gemcitabine, carboplatin and bevacizumab in advanced stage non-squamous non-small cell lung cancer
    Clement-Duchene, Christelle
    Krupitskaya, Yelena
    Ganjoo, Kristen
    Lavori, Philip
    Kumar, Atul
    Zhao, Gary
    Padda, Sukhami
    San Pedro-Salcedo, Melanie
    Wakelee, Heather
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S674 - S674
  • [47] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131
  • [48] Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer
    Liu, Yuhua
    Mao, Aihong
    Ma, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9049 - 9057
  • [49] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
    Shiraishi, Yoshimasa
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
  • [50] Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
    Schneider, Benjamin K.
    Boyer, Arnaud
    Ciccolini, Joseph
    Barksi, Fabrice
    Wang, Kenneth
    Benzekry, Sebastien
    Mochel, Jonathan P.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (08): : 577 - 586
12345